Matthew D. Galsky

Everything you need to know about cancer in language you can actually understand

Matthew D. Galsky, 2013 .

848PDImpact of zumor mutation burden on nivolumab efficacy in second-line urothelial carcinoma patients: Exploratory analysis of the phase ii checkmate 275 study

Matthew D. Galsky, Alexandre Lambert, C. Horak, 2017 .

Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

Juan P. Wisnivesky, Matthew D. Galsky, G. Sonpavde, 2013, World Journal of Urology.

Abstract 368: Inferred regulatory interaction network from prostate cancer reveals potential regulators coordinating progression and metastasis

Xudong Dai, Eric E. Schadt, Jun Zhu, 2014 .

Use of crowdsourcing for cancer clinical trial development.

Matthew D. Galsky, John Holland, Alex Greenberg, 2014 .